Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 2 |
Microsoft
MSFT
|
+$671M |
| 3 |
Spotify
SPOT
|
+$586M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$406M |
Top Sells
| 1 |
Apple
AAPL
|
+$2.7B |
| 2 |
Amazon
AMZN
|
+$1.48B |
| 3 |
Merck
MRK
|
+$884M |
| 4 |
Broadcom
AVGO
|
+$823M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$698M |
Sector Composition
| 1 | Technology | 15.81% |
| 2 | Healthcare | 13.31% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 11.5% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3826
WELLS FARGO 7.5% NON CUMV PERP CONV
WFC.PRL
$4.96B
| $35.6K | ﹤0.01% |
+28,000
| New | +$35.6K |
|
3827
Entravision Communication
EVC
$215M
| $35.2K | ﹤0.01% |
17,024
-16,633
| -49% | -$34.4K |
|
3828
FibroBiologics
FBLG
$22.8M
| $34.7K | ﹤0.01% |
11,221
-13,128
| -54% | -$40.6K |
|
|
UROY
3829
Uranium Royalty Corp
UROY
$438M
| $34K | ﹤0.01% |
13,971
-313,666
| -96% | -$762K |
|
|
RPT
3830
Rithm Property Trust Inc.
RPT
$123M
| $33.7K | ﹤0.01% |
10,128
-17,524
| -63% | -$58.4K |
|
|
XNET
3831
Xunlei
XNET
$454M
| $33.6K | ﹤0.01% |
18,154
+3,456
| +24% | +$6.39K |
|
|
MNDR
3832
Mobile-health Network Solutions
MNDR
$4.73M
| $32.6K | ﹤0.01% |
6,686
-1,482
| -18% | -$7.23K |
|
|
LFLY
3833
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
| $32.3K | ﹤0.01% |
15,372
-1,904
| -11% | -$4K |
|
3834
Harvard Bioscience
HBIO
$20M
| $32.2K | ﹤0.01% |
11,952
-136,470
| -92% | -$367K |
|
3835
Immix Biopharma
IMMX
$63.1M
| $32.1K | ﹤0.01% |
21,521
-4,779
| -18% | -$7.12K |
|
3836
Vivos Therapeutics
VVOS
$28.6M
| $31.3K | ﹤0.01% |
+12,001
| New | +$31.3K |
|
|
QSG
3837
QuantaSing Group
QSG
$450M
| $31.1K | ﹤0.01% |
13,413
-8,896
| -40% | -$20.6K |
|
3838
OmniAb
OABI
$226M
| $30.9K | ﹤0.01% |
124,752
-905,696
| -88% | -$225K |
|
3839
Xtant Medical Holdings
XTNT
$80.8M
| $30.7K | ﹤0.01% |
45,363
-17,319
| -28% | -$11.7K |
|
|
AXDX
3840
DELISTED
Accelerate Diagnostics
AXDX
| $29.1K | ﹤0.01% |
17,012
-2,572
| -13% | -$4.4K |
|
3841
Verrica Pharmaceuticals
VRCA
$47.7M
| $29K | ﹤0.01% |
+2,003
| New | +$29K |
|
3842
IZEA Worldwide
IZEA
$63.1M
| $28.9K | ﹤0.01% |
10,522
-2,542
| -19% | -$6.99K |
|
|
ENZ
3843
DELISTED
Enzo Biochem, Inc.
ENZ
| $28.8K | ﹤0.01% |
25,745
+6,382
| +33% | +$7.15K |
|
3844
ChargePoint
CHPT
$235M
| $28.6K | ﹤0.01% |
+1,042
| New | +$28.6K |
|
|
OCFT
3845
OneConnect Financial Technology
OCFT
$281M
| $28.4K | ﹤0.01% |
+10,158
| New | +$28.4K |
|
3846
Complete Solaria, Inc. Common Stock
SPWR
$125M
| $28.3K | ﹤0.01% |
+10,068
| New | +$28.3K |
|
3847
DigiAsia
FAAS
$12.3M
| $27.4K | ﹤0.01% |
14,031
-28,945
| -67% | -$56.4K |
|
3848
Akebia Therapeutics
AKBA
$777M
| $26.7K | ﹤0.01% |
20,245
-25,440
| -56% | -$33.6K |
|
3849
Mawson Infrastructure Group
MIGI
$7.3M
| $26.4K | ﹤0.01% |
21,326
-10,521
| -33% | -$13K |
|
|
MAAS
3850
Maase Inc. Class A Ordinary Shares
MAAS
$887M
| $26.4K | ﹤0.01% |
+344
| New | +$26.4K |
|